Dialysis & Renal Transplantation | Methods for Diagnostic & Therapeutic Studies | Renal & Gastrointestinal Problems in Critical Care | Renal Pharmacology
The effects of pentoxifylline on peritoneal functions and cytokine levels on continuous ambulatory peritoneal dialysis patients
Havva Yesil*, Saime Paydas, Mustafa Balal, Ümit Çinkir, Yasar Sertdemir
*Corresponding author: Havva Yesil
Internal Medicine, Çukurova University, Adana, Turkey
F1000Posters 2011, 2: 1375 (slide presentation) [ENGLISH]
Slide Presentation [192.5 KB]
Presented at
48th Congress of the European Renal Association and European Dialysis and Transplant Association 2011,
23 - 26 Jun 2011, Sa-336
In this study we evaluated the effect of pentoxifylline on peritoneal permeability and function.
Main conclusion: Stable CAPD patients treated with pentoxyfilline for three weeks, had no change in peritoneal permeability, peritoneal function, body weight or urine volume according to the baseline levels provided at the end of the pentoxifylline therapy.
No relevant conflicts of interest declared.
Please note that most posters on this site present work that is preliminary in nature and has not been peer reviewed.
This poster is open access subject to the CC BY-NC Creative Commons 3.0 License
